Eaton Vance Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $108M | Buy |
|
|||||
|
2022
Q2 | $31.2M | Sell |
|
|||||
|
2022
Q1 | $32.1M | Buy |
|
|||||
|
2021
Q4 | $30.4M | Sell |
|
|||||
|
2021
Q3 | $25.2M | Buy |
|
|||||
|
2021
Q2 | $22.2M | Sell |
|
|||||
|
2021
Q1 | $17.9M | Sell |
|
|||||
|
2020
Q4 | $32.4M | Sell |
|
|||||
|
2020
Q3 | $81M | Sell |
|
|||||
|
2020
Q2 | $88.9M | Sell |
|
|||||
|
2020
Q1 | $89.2M | Sell |
|
|||||
|
2019
Q4 | $88.2M | Buy |
|
|||||
|
2019
Q3 | $77.7M | Sell |
|
|||||
|
2019
Q2 | $76.7M | Buy |
|
|||||
|
2019
Q1 | $78.5M | Sell |
|
|||||
|
2018
Q4 | $69.6M | Sell |
|
|||||
|
2018
Q3 | $71.5M | Sell |
|
|||||
|
2018
Q2 | $70.2M | Sell |
|
|||||
|
2018
Q1 | $149M | Buy |
|
|||||
|
2017
Q4 | $81.7M | Sell |
|
|||||
|
2017
Q3 | $73.5M | Sell |
|
|||||
|
2017
Q2 | $65.8M | Sell |
|
|||||
|
2017
Q1 | $53.2M | Sell |
|
|||||
|
2016
Q4 | $56.2M | Sell |
|
|||||
|
2016
Q3 | $65.5M | Sell |
|
|||||
|
2016
Q2 | $86.1M | Sell |
|
|||||
|
2016
Q1 | $91.8M | Sell |
|
|||||
|
2015
Q4 | $101M | Sell |
|
|||||
|
2015
Q3 | $95.3M | Sell |
|
|||||
|
2015
Q2 | $96.4M | Sell |
|
|||||
|
2015
Q1 | $95.2M | Sell |
|
|||||
|
2014
Q4 | $75.7M | Sell |
|
|||||
|
2014
Q3 | $85.2M | Sell |
|
|||||
|
2014
Q2 | $82.9M | Sell |
|
|||||
|
2014
Q1 | $85.7M | Sell |
|
|||||
|
2013
Q4 | $74.4M | Sell |
|
|||||
|
2013
Q3 | $70.4M | Sell |
|
|||||
|
2013
Q2 | $64.7M | Buy |
|